Suchen Sie nach Informationen zu Glaxosmithkline-Unternehmensbüros? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.


Home | GSK US

    https://us.gsk.com/en-us/home/
    Press releases. 11 July 2022 GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses. 01 July 2022 GSK completes acquisition of Sierra Oncology. 29 June 2022 GSK selects Target the Future grant recipient in innovation challenge supporting multiple myeloma community. View all Press Releases.

Headquarters | GSK US

    https://us.gsk.com/en-us/contact-us/headquarters/
    Our global headquarters are in the UK but we also have a significant presence in the USA

GlaxoSmithKline Pharmaceuticals

    https://glaxosmithklinepharmaceutical.com/
    Glaxo Smithline Pharmaceuticals Ltd. We are well established wholesale and distribution firm, engaged in the supply of pharmaceuticals, research chemicals, and pharmaceutical intermediaries, based in India.We are determined to establish a lasting business relationship with you and your esteemed organization in the supply.

Headquarters | GSK

    https://www.gsk.com/en-gb/contact-us/headquarters/
    Our global headquarters are in the UK but we also have a significant presence in the USA

GlaxoSmithKline B.V. Company Profile | Amersfoort, …

    https://www.dnb.com/business-directory/company-profiles.glaxosmithkline_bv.1c05b7ed1372aa2a03304bda182cff01.html
    Company Description: GlaxoSmithKline B.V. is located in Amersfoort, UTRECHT, Netherlands and is part of the Drugs and Druggists' Sundries Merchant Wholesalers Industry. GlaxoSmithKline B.V. has 449 total employees across all of its locations and generates $182.27 million in sales (USD). (Employees figure is estimated).

Investors | GSK

    https://www.gsk.com/en-gb/investors/
    Quarterly results. 27 July 2022. We will announce our second quarter July results at 07:00 BST, 02:00 EDT on Wednesday 27 July. Following the announcement there will be a webcast hosted by Emma Walmsley, CEO, and other members of the GSK Leadership Team at 12:00 BST, 07:00 EDT.

glaxosmithkline.ltd

    https://glaxosmithkline.ltd/
    glaxosmithkline.ltd aims at Empowering investors by providing them an avenue for controlling their financial future via providing outstanding services, innovation, and expertise in the fast raising Crypto Currency Market . glaxosmithkline.ltd is dedicated to helping investors around the world reach their desired investment goals and broaden their financial horizons.

GlaxoSmithKline AG Company Profile - Dun & Bradstreet

    https://www.dnb.com/business-directory/company-profiles.glaxosmithkline_ag.d48d8f65c4202441ef802691492a0b64.html
    Company Description: GlaxoSmithKline AG is located in Münchenbuchsee, BERN, Switzerland and is part of the Pharmaceutical and Medicine Manufacturing Industry. GlaxoSmithKline AG has 167 employees at this location and generates $40.76 million in sales (USD). (Sales figure is modelled).

GlaxoSmithKline To Spin-Off Consumer Healthcare …

    https://www.forbes.com/sites/joecornell/2021/07/15/glaxosmithkline-to-spin-off-consumer-healthcare-business-by-mid-2022/
    Deal Overview. On June 23, 2021, GlaxoSmithKline plc (NYSE: GSK, $40.45, Market Cap: $101.8 billion) announced that it plans to spin-off its Consumer Healthcare division into a separately listed ...

GlaxoSmithKline demerger: GSK spin-off Haleon date and details …

    https://capital.com/gsk-demerger-haleon-glaxosmithkline-spin-off-share-split
    GlaxoSmithKline (), one of the UK’s largest biotech stocks, has demerged from its consumer healthcare business and a new company has been formed called Haleon, which started trading on the London Stock Exchange (LSE) on Monday 18 July.Haleon has become the world’s biggest standalone consumer health group and Europe’s biggest listing in a decade and will …

Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Glaxosmithkline-Unternehmensbüros gefunden haben.